Bispecific Antibodies in the Management of Multiple Myeloma
May 24, 2024
42:09
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Dr Joshua Richter from the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai in New York, New York, discusses the role of bispecific antibodies in multiple myeloma.
Oncology Today with Dr Neil Love